DRUG SHORTAGES: NAVIGATING THE CHALLENGE
DRUG SHORTAGES: NAVIGATING THE CHALLENGE
SUNDAY/9:45-10:45AM
ACPE UAN: 0107-9999-20-032-L03-P 0107-9999-20-032-L03-T
Activity Type: Knowledge-Based
0.1 CEU/1.0 hr 0.1 CEU/1.0 hr
Learning Objectives for Pharmacists & Pharmacy Technicians:
Upon completion of this CPE course participants should be able to:
1. Describe recent trends in the causes of drug shortages. 2. Discuss federal regulations related to manufacturing and how recent quality trends relate to drug shortages. 3. Evaluate potential solutions to the drug shortage problem.
Speaker: Erin Fox, PharmD, BCPS, FASHP Erin Fox completed a Drug Information Specialty Residency after graduating from the University of Utah College of Pharmacy in 1999. She serves as secretary of the P&T Committee and residency program director for the PGY2 Medication-Use Safety & Policy residency. Areas of interest include drug shortages, medication use policy, drug information, evidence based medicine, and drug costs. Erin frequently serves as a media resource regarding drug shortages and drug prices.
Speaker Disclosure: Erin Fox reports an affiliation with the University of Utah Drug Information Service, which has a contract to provide drug shortage information to Vizient. Off-label use of medications will not be discussed during this presentation.
Drug Shortages ? Navigating the Challenges
Erin R. Fox, PharmD, BCPS, FASHP Twitter: @foxerinr
#RxExpo20
1
Disclosure
? This presentation represents my own opinions ? University of Utah Drug Information Service has a contract with
Vizient (a GPO) to provide drug shortage information. The total amount is < 5% of total budget. ? University of Utah Health is a Vizient member
#RxExpo20
2
Learning Objectives
? Upon successful completion of this course, participants should be able to:
? Describe recent trends in the causes of drug shortages. ? Discuss federal regulations related to manufacturing and how
recent quality trends relate to drug shortages. ? Evaluate potential solutions to the drug shortage problem.
#RxExpo20
3
University of Utah Drug Information and Drug Shortages
? Provide drug shortage content for ASHP ? Public website at shortages ? Partners since 2001 ? Voluntary reports are confirmed with manufacturers ? Collaborate with FDA's drug shortage team
#RxExpo20
4
Current Trends
#RxExpo20
5
National Drug Shortages - New Shortages by Year January 2001 to December 31, 2019
300 267
250 200 150 120
211 166 149 129
204
185
186
140
142 154 146
166
100
88 73 58 74 70
50
0 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19
Note: Each column represents the number of new shortages identified during that year. University of Utah Drug Information Service Erin.Fox@hsc.utah.edu, @foxerinr
#RxExpo20
6
National Drug Shortages - New Shortages by Year January 2001 to December 31, 2019, % Injectable
300 57%
250 200 150
73%
63%
55% 45% 61%
46%
45%
50%
45% 63% 58%
55% 39%
100
64% 52% 57% 64% 60%
50
0 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19
Note: Each column represents the number of new shortages identified during that year. Green = injectable, yellow = non-injectable University of Utah Drug Information Service Erin.Fox@hsc.utah.edu, @foxerinr
#RxExpo20
7
National Drug Shortages ? Active Shortages by Quarter
350
300
305 306 320 301
250 200
265 219
224
238
251
276
282 265
264
190 185 195 191 174 176 176 174 174 183 202
150
100
50
0
Note: Each point represents the number of active shortages at the end of each quarter. University of Utah Drug Information Service Erin.Fox@hsc.utah.edu, @foxerinr
#RxExpo20
8
Active Shortages Top 5 Drug Classes
Active Shortages December 31, 2019
60
50
40
21
30
20
19
11
30
10 12
17
17
0
2
Antimicrobials
Chemotherapy
Cardiovascular
CNS
University of Utah Drug Information Service Erin.Fox@hsc.utah.edu, @foxerinr Green = injectable, yellow = non-injectable
9
Injectable Non-injectable
2 19 Ophthalmic
#RxExpo20
What do these numbers mean?
? The rate of new shortages is slowing, but long-term active and ongoing shortages are not resolving
? Trend this year is for more oral and topical products in short supply, especially cardiovascular (ARBs) and ophthalmic products
? Significantly more suppliers would not provide a reason for shortages (this is more common for non-injectable companies)
? FDA's Drug Shortage Task Force Report notes that more than 60% of shortages are due to quality issues at the manufacturer
?
? ?
Shortages-as-Matter-of-NatlSecurity.ashx?la=en&hash=FA494117C6255A5493F77B67EDE39DD28B790FAD
#RxExpo20
10
What's making current numbers feel worse?
? Shortages of basic products impacting most patients ? High risk medications (opioids) ? EHR, automation, smart pumps
? All designed to require the use of the same product, all of the time
? Large amounts of product needed ? Uncertainty about compounding regulations ? Disruption in 503b market
#RxExpo20
11
Quality
12
#RxExpo20
#RxExpo20
13
#RxExpo20
14
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- exforge amlodipine valsartan 5 160 mg 10 160 mg 5 320
- drug shortages navigating the challenge
- can common blood pressure medications cause diabetes
- tainted drugs ex fda inspector warns of dangers in u s
- amlodipine besylate tablets food and drug administration
- micardis warnings and precautions
- patient information diovan dye o van valsartan
- making sense of the recent blood pressure drug recalls
- metformin shortage medsask
Related searches
- do the write thing challenge 2019
- accept the challenge synonym
- the best drug discount card
- guess the song challenge youtube
- nursing shortages and patient safety
- do the right thing challenge poems
- guess the age challenge quiz
- best over the counter home drug test
- drug use in the usa
- the atoms family atomic math challenge answer
- the cost of drug abuse
- the history of drug addiction